Rajiv Gala
Obstetrics & Gynecology · New Orleans, LANPI 1477519775
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,175 of the $1,435 with a category attached, or 81.8%. It is spread thinly across 25 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $418 and has fallen 78.6% since, to $90 in 2025.
Across 64 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$321
- AbbVie$230
- Astellas Pharma US Inc$181
- Pfizer$180
- Hologic Sales And Service, LLC$77
- Millicent US Inc$53
- plus $393 from 19 others
Across 2 payments — averaging $16,039 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Organon$32K
What the payments were for
- Travel & lodging$16011%
- Food & beverage$1,17582%
- Education$1017%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 3 | $321 |
| AbbVie | 12 | $230 |
| Astellas Pharma US Inc | 10 | $181 |
| Pfizer | 10 | $180 |
| Hologic Sales And Service, LLC | 3 | $77 |
| Millicent US Inc | 3 | $53 |
| Coopersurgical, Inc. | 3 | $53 |
| Asensus Surgical, Inc. | 2 | $36 |
| Biom'up SA | 1 | $31 |
| Avanos Medical | 1 | $31 |
| Avion Pharmaceuticals | 2 | $27 |
| Organon | 1 | $26 |
| Exact Sciences | 1 | $21 |
| Scynexis, Inc. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $20 |
| Meditrina | 1 | $17 |
| Merck | 1 | $17 |
| Gen-probe Sales & Service, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Covidien LP | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Minerva Surgical, Inc | 1 | $11 |
| Evofem Biosciences, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$522
How this compares
$1,435 in reported general payments places this provider in the 55th percentile of 608 obstetrics & gynecology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $219 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New Orleans
- Veronica GillispieNew Orleans$117K
- Earl PeeperNew Orleans$95K
- George MorrisNew Orleans$34K
- Janifer TropezNew Orleans$27K
- Roeland VanopijnenNew Orleans$19K
- Robin BoneNew Orleans$18K
- Diana DangNew Orleans$17K
- Jennifer BrunetNew Orleans$11K
- Julie TaggartNew Orleans$10K
- Candace MooreNew Orleans$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.